Decoy Therapeutics (DCOY) vs Onconetix (ONCO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Decoy Therapeutics is the larger company by market cap ($3.5 million vs $3.3 million), about 1.1 times the size. On valuation, Onconetix trades at a lower trailing P/E (0.0x vs 0.1x for Decoy Therapeutics).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCOY | ONCO |
|---|---|---|
| Share price | $1.48 | $0.6358 |
| Market cap | $3.53M | $3.33M |
| 1-day change | -2.63% | -2.83% |
| P/E ratio (TTM) | 0.12 | 0.00 |
| EPS (TTM) | $12.74 | $310.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.92 | $207.00 |
| 52-week low | $1.46 | $0.58 |
| Distance from 52-week high | -97.35% | -99.69% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +102.70% | — |
| Average volume | 2.17M | 2.96M |
| Shares outstanding | 2.39M | 5.24M |
| Employees | 11 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Decoy Therapeutics trades at a higher earnings multiple (0.1x vs 0.0x trailing P/E).
About Decoy Therapeutics
DCOY stock →Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees
About Onconetix
ONCO stock →Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
DCOY vs ONCO FAQ
Which is bigger, Decoy Therapeutics or Onconetix?
Decoy Therapeutics (DCOY) is larger, with a market capitalization of $3.53M compared with $3.33M for Onconetix (ONCO).
Which has the lower P/E ratio, DCOY or ONCO?
ONCO has the lower trailing P/E at 0.0, versus 0.1 for DCOY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Decoy Therapeutics and Onconetix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.